RGEN (STOCKS)
Repligen Corp
$132.670000
-6.730000 (-4.83%)
Prev close: $139.400000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Olivier Dominique Loeillot
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $7,477.05M
- Employees
- 1,778
- P/E (TTM)
- 5,160.70
- P/B (TTM)
- 3.58
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
7
Strong Buy
16
Buy
5
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$0.46 | $0.43 | +0.0332 | +7.78% |
|
Jun 2025 (Q2)
|
$0.37 | $0.40 | -0.0271 | -6.82% |
|
Mar 2025 (Q1)
|
$0.39 | $0.35 | +0.0378 | +10.73% |
|
Dec 2024 (Q4)
|
$0.44 | $0.42 | +0.0218 | +5.21% |
Financial Statements
| Revenues | $707.89M |
| Benefits Costs and Expenses | $703.23M |
| Cost Of Revenue | $386.64M |
| Costs And Expenses | $707.09M |
| Gross Profit | $321.26M |
| Nonoperating Income/Loss | $3.86M |
| Operating Expenses | $320.46M |
| Selling, General, and Administrative Expenses | $276.62M |
| Depreciation and Amortization | $77.16M |
| Research and Development | $52.73M |
| Operating Income/Loss | $798.00K |
| Income/Loss From Continuing Operations After Tax | $1.74M |
| Income/Loss From Continuing Operations Before Tax | $4.66M |
| Income Tax Expense/Benefit | $2.92M |
| Income Tax Expense/Benefit, Deferred | -$18.41M |
| Net Income/Loss | $1.74M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $1.74M |
| Net Income/Loss Available To Common Stockholders, Basic | $1.74M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $0.02 |
| Diluted Earnings Per Share | $0.02 |
| Basic Average Shares | 112,485 |
| Diluted Average Shares | 112,663 |
| Assets | $2.92B |
| Current Assets | $1.10B |
| Inventory | $160.32M |
| Other Current Assets | $936.17M |
| Noncurrent Assets | $1.83B |
| Fixed Assets | $188.93M |
| Intangible Assets | $395.44M |
| Other Non-current Assets | $1.24B |
| Liabilities | $840.62M |
| Current Liabilities | $131.14M |
| Accounts Payable | $29.43M |
| Wages | $36.04M |
| Other Current Liabilities | $65.67M |
| Noncurrent Liabilities | $709.49M |
| Long-term Debt | $537.93M |
| Other Non-current Liabilities | $171.56M |
| Equity | $2.08B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $2.08B |
| Liabilities And Equity | $2.92B |
| Net Cash Flow From Operating Activities | $130.89M |
| Net Cash Flow From Operating Activities, Continuing | $130.89M |
| Net Cash Flow From Investing Activities | -$154.49M |
| Net Cash Flow From Investing Activities, Continuing | -$154.49M |
| Net Cash Flow From Financing Activities | -$13.95M |
| Net Cash Flow From Financing Activities, Continuing | -$13.95M |
| Net Cash Flow | -$37.55M |
| Net Cash Flow, Continuing | -$37.55M |
| Comprehensive Income/Loss | $32.25M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $32.25M |
| Other Comprehensive Income/Loss | $32.25M |